Measles virus infection and subacute sclerosing panencephalitis

Birkhauser Advances in Infectious Diseases

Volumn , Issue , 2013, Pages 3-22

  Anlar, Banu ^a   Yalaz, Kalbiye ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Demyelinating; Immunoglobulin; Magnetic resonance imaging; Measles; Subacute sclerosing panencephalitis

Indexed keywords

ALPHA INTERFERON; AMANTADINE; CARBAMAZEPINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHISOPRINOL; RIBAVIRIN; VIRUS ANTIGEN; VIRUS RNA;

ACUTE DISEASE; ARTICLE; ATAXIA; BEHAVIOR CHANGE; BRAIN BIOPSY; BRAIN RADIOGRAPHY; CELL INCLUSION; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID EXAMINATION; CHOREA MINOR; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; GLIOSIS; HUMAN; HYPERURICEMIA; IMMUNOCOMPETENCE; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; INFECTION RISK; LEUKODYSTROPHY; MEASLES; MEASLES VACCINATION; MOLECULAR PATHOLOGY; MYOCLONUS EPILEPSY; NEPHROLITHIASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RISK ASSESSMENT; RISK FACTOR; STOMACH DISEASE; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS MENINGITIS; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; WILSON DISEASE;

EID: 84866465247     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-0425-7_1     Document Type: Article

References (73)

1. Adels BR, Gajdusek C, Gibbs CJ Jr, Albrecht P, Rogers NG (1968) Attempts to transmit subacute sclerosing panencephalitis and isolate a measles virus related agent, with a study of the immune response in patients and experimental animals. Neurology 18:30-51.
2. Albertyn C, van der Plas H, Hardie D, Candy S, Tomoka T, Leepan EB, Heckmann JM (2011) Silent casualties from the measles outbreak in South Africa. S Afr Med J 101:313-314, 316-317.
3. Anlar B, Yalaz K (2011) Prognosis in subacute sclerosing panencephalitis. Dev Med Child Neurol 53:965.
4. Anlar B, Saatçi I, Kose G, Yalaz K (1996) MRI findings in subacute sclerosing panencephalitis. Neurology 47:1278-1283.
5. Anlar B, Yalaz K, Oktem F, Kose G (1997) Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology 48:526-528.
6. Anlar B, Köse G, Gürer Y, Altunbaşak S, Haspolat S, Okan M (2001a) Changing epidemiological features of subacute sclerosing panencephalitis. Infection 29:192-195.
7. Anlar B, Söylemezoǧlu F, Aysun S, Köse G, Belen D, Yalaz K; (2001b) Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE). J Child Neurol 16:895-900.
8. Anlar B, Ayhan A, Hotta H, Itoh M, Engin D, Barun S, Koseoglu O (2002a) Measles virus RNA in tonsils of asymptomatic children. J Paediatr Child Health 38:424-425.
9. Anlar B, Pinar A, Yaşar Anlar F, Engin D, Ustaçelebi S, Kocagöz T, Us D, Akduman D, Yalaz K; (2002b) Viral studies in the cerebrospinal fluid in subacute sclerosing panencephalitis. J Infect 44:176-180.
10. Anlar B, Aydin OF, Guven A, Sonmez FM, Kose G, Herguner O (2004) Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis. Clin Ther 26:1890-1894.
11. Bakir TF (1989) Viral meningitis and encephalitis in Saudi Arabia. J Trop Pediatr 35:211-213.
12. Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, Shieh WJ, Rota PA (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192:1686-1693.
13. Bouteille M, Fontaine C, Vedrenne C, Delarue J (1965) Sur un cas d'encbphalite subaigue a inclusions. Etude anatomoclinique et ultrastructurale. Rev Neurol 113:454.
14. Cherian T, Joseph A, John TJ (1984) Low antibody response in infants with measles and children with subclinical measles virus infection. J Trop Med Hyg 87:27-31.
15. Committee on Infectious Diseases; American Academy of Pediatrics (2011) Policy statement-recommended childhood and adolescent immunization schedules-United States, 2011. Pediatrics 127:387-388.
16. Connolly JH, Haire M, Hadden DS (1971) Measles immunoglobulins in subacute sclerosing panencephalitis. Br Med J 1:23-25.
17. Dittmar S, Harms H, Runkler N, Maisner A, Kim KS, Schneider-Schaulies J (2008) Measles virusinduced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol 82:11273-11282.
18. Dyken PR, Swift A, DuRant RH (1982) Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 11:359-363.
19. Erturk O, Karslιgil B, Cokar O, Yapιcι Z, Demirbilek V, Gurses C, Yalcinkaya C, Gokyigit A, Direskeneli GS, Yentur S, Onal E, Yιlmaz G, Dervent A (2011) Challenges in diagnosing SSPE. Childs Nerv Syst 27:2041-2044.
20. European Centre for Disease Prevention and Control (ECDC). European monthly measles monitoring (EMMO) 2011. Stockholm. http://ecdc.europa.eu/en/publications/Publications/1109_European_monthly_measles_monitoring_August_2011.pdf.
21. Filia A, Tavilla A, Bella A, Magurano F, Ansaldi F, Chironna M, Nicoletti L, Palù G, Iannazzo S, Declich S, Rota MC (2011). Measles in Italy, July 2009 to September 2010. Euro Surveill 16: pii: 19925.
22. Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T, Arima M, Yabuuchi H, Ueda S, Ohtahara S et al (1987) Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis-a multi-institutional collaborative study-The Inosiplex-SSPE Research Committee. Brain Dev 9:270-282.
23. Gadoth N, Kott E, Levin S, Hahn T (1989) The interferon system in subacute sclerosing panencephalitis and its response to isoprinosine. Brain Dev 11:308-312.
24. Gibbs FA, Gibbs EL, Spies HW, Carpenter PR (1964) Common types of childhood encephalitis: electroencephalographic and clinical relationships. Arch Neurol 10:1-11.
25. Gunaratne PS, Rajendran T, Tilakaratne S (2001) Neurological complications of measles. Ceylon Med J 46:48-50.
26. Gurer YK, Kukner S, Sarica B (1996) Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol 14:72-74.
27. Haddad FS, Risk WS (1980) Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study. Ann Neurol 7:185-188.
28. Hirayama T, Ikeda K, Hidaka T, Nagata R, Yoshii Y, Kawabe K, Iwasaki Y (2010) Unilateral measles-associated retrobulbar optic neuritis without encephalitis: a case report and literature review. Case Rep Neurol 2:128-132.
29. Horta-Barbosa L, Fuccillo DA, London WT, Jabbour JT, Zeman W, Sever JL (1969) Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med 132:272-277.
30. Jones CE, Dyken PR, Huttenlocher PR, Jabbour JT, Maxwell K (1982) Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients. Lancet 1:1034-1037.
31. Katayama Y, Kohso K, Nishimura A, Tatsuno Y, Homma M, Hotta H (1998) Detection of measles virus mRNA from autopsied human tissues. J Clin Microbiol 36:299-301.
32. Katz M, Rorke LB, Masland WS, Koprowski H, Tucker SH (1968) Transmission of an encephalitogenic agent from brains of patients with subacute sclerosing panencephalitis to ferrets. Preliminary report. N Engl J Med 279:793-798.
33. Kim SJ, Kim JS, Lee DY (2003) Neurologic outcome of acute measles encephalitis according to the MRI patterns. Pediatr Neurol 28:281-284.
34. Kuhne Simmonds M, Brown DW, Jin L (2006) Measles viral load may reflect SSPE disease progression. Virol J 3:49.
35. Laboccetta AC, Tornay AS (1964) Measles encephalitis. Report of 61 cases. Am J Dis Child 107:247-255.
36. Lee KY, Cho WH, Kim SH, Kim HD, Kim IO (2003) Acute encephalitis associated with measles: MRI features. Neuroradiology 45:100-106.
37. Lisse I, Samb B, Whittle H, Jensen H, Soumare M, Simondon F, Aaby P (1998) Acute an d longterm changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scand J Infect Dis 30:17-21.
38. Luzi P, Leoncini L, Valassina M, Federico A, Palma L (1997) Chronic progressive leptomeningitis associated with measles virus. Lancet 350:338-339.
39. Maas S, Kawahara Y, Tamburro KM, Nishikura K (2006) A-to-I RNA Editing and Human Disease. RNA Biol 3:1-9.
40. Meyer E, Byers RK (1952) Measles encephalitis; a follow up study of sixteen patients. AMA Am J Dis Child 84:543-579.
41. Miki K, Komase K, Mgone CS, Kawanishi R, Iijima M, Mgone JM, Asuo PG, Alpers MP, Takasu T, Mizutani T (2002) Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. J Med Virol 68:105-112.
42. Moss WJ, Griffin DE (2012) Measles. Lancet 2012 379:153-164.
43. Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD (1993) Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 16:654-660.
44. Nakajima M, Sakuishi K, Fukuda S, Fujioka S, Hashida H (2008) Recovery from adult measles encephalitis immediately after early immunomodulation. Clin Infect Dis 47:148-149.
45. Nakayama T, Mori T, Yamaguchi S, Sonoda S, Asamura S, Yamashita R, Takeuchi Y, Urano T (1995) Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res 35:1-16.
46. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025-6032.
47. Oktem F, Nester MJ, Anlar B (1997) Mental assessment in subacute sclerosing panencephalitis: Hacettepe Cognitive Short Assessment Scale. J Child Neurol 12:398-402.
48. Olmez A, Yilmaz D, Tan H, Duman O, Gungor S, Okuyaz C, Anlar B (2007) Cerebrospinal fluid pressures in subacute sclerosing panencephalitis. Brain Dev 29:409-412.
49. Otaki M, Jiang DP, Sasayama M, Nagano-Fujii M, Hotta H (2007) Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus. Microbiol Immunol 51:985-991.
50. Paunio M, Hedman K, Davidkin I, Valle M, Heinonen OP, Leinikki P, Salmi A, Peltola H (2000) Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect 124:263-271.
51. Pipo-Deveza JR, Kusuhara K, Silao CL, Lukban MB, Salonga AM, Sanchez BC, Kira R, Takemoto M, Ishizaki Y, Yukaya N, Kusuhara K, Kira R, Torisu H, Ihara K, Sakai Y, Sanefuji M, Pipo-Deveza JR, Silao CL, Sanchez BC, Lukban MB, Salonga AM, Hara T (2010) PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis. Hum Genet 127:411-419.
52. Piskin AK, Akpinar P, Muftuoglu S, Anlar B (2007) Signaling lymphocyte activating molecule (SLAM) expression in subacute sclerosing panencephalitis. Brain Dev 29:439-442.
53. Plaza JA, Nuovo GJ (2005) Histologic and molecular correlates of fatal measles infection in children. Diagn Mol Pathol 14:97-102.
54. Prasad SR, Shaikh NJ, Verma S, Banerjee K (1995) IgG & IgM antibodies against measles virus in unvaccinated infants from Pune: evidence for subclinical infections. Indian J Med Res 101:1-5.
55. Prashanth LK, Taly AB, Sinha S, Ravi V (2007) Subacute sclerosing panencephalitis (SSPE): an insight into the diagnostic errors from a tertiary care university hospital. J Child Neurol 22:683-688.
56. Reuter D, Schneider-Schaulies J (2010) Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol 199:261-271.
57. Robertson WC Jr, Clark DB, Markesbery WR (1980) Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease. Ann Neurol 8:422-425.
58. Sever AE, Rainey JJ, Zell ER, Hennessey K, Uzicanin A, Castillo-Solórzano C, Dietz V (2011) Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule. J Infect Dis 204(Suppl 2):S748-755.
59. Shu M, Liu Q, Wang J, Ao R, Yang C, Fang G, Wan C, Guo W (2011) Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008. Vaccine 29:3507-3510.
60. Srivastava SP, Nema HV (1963) Optic neuritis in measles. Brit J Ophthal 47:180-181.
61. Stanescu A, Janta D, Lupulescu E, Necula G, Lazar M, Molnar G, Pistol A (2011) Ongoing measles outbreak in Romania, 2011. Euro Surveill 16: pii:19932.
62. Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897.
63. Thurner B, Spangenberg P, Kleines M, Blaum M, Scheithauer S, Hausler M (2007) Continuous intrathecal interferon alpha application in subacute sclerosing panencephalitis. Pediatr Infect Dis J 26:863.
64. Tomiyasu K, Ishiyama M, Kato K, Komura M, Ohnuma E, Inamasu J, Takahashi T (2009) Bilateral retrobulbar optic neuritis, Guillain-Barré syndrome and asymptomatic central white matter lesions following adult measles infection. Intern Med 48:377-381.
65. Tomoda A, Nomura K, Shiraishi S, Hamada A, Ohmura T, Hosoya M, Miike T, Sawaishi Y, Kimura H, Takashima H, Tohda Y, Mori K, Kato Z, Fukushima A, Nishio H, Nezu A, Nihei K (2003) Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain Dev 25:514-517.
66. Torisu H, Hara T (2006) Analysis of MxA, IL-4, and IRF-1 genes in Filipino patients with subacute sclerosing panencephalitis. Neuropediatrics 37:222-228.
67. Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, Sanefuji M, Takemoto M, Hara T (2004) Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 62:457-460.
68. Tyler HR (1957) Neurological complications of rubeola (measles). Medicine (Baltimore) 36:147-167.
69. Valassina M, Meacci F, Valensin PE, Cusi MG (2000) Detection of neurotropic viruses circulating in Tuscany: the incisive role of Toscana virus. J Med Virol 60:86-90.
70. Watanabe A, Yoneda M, Ikeda F, Terao-Muto Y, Sato H, Kai C (2010) CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J Virol 84:4183-93.
71. Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y (1992) Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 42:488-491.
72. Yilmaz V, Demirbilek V, Gürses C, Yentür SP, Uysal S, Yapici Z, Yilmaz G, Muncey A, Cokar O, Onal E, Gökyiǧit A, (2007) Interleukin (IL)-12, IL-2, interferongamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13:410-415.
73. Yuksel D, Sonmez PA, Yilmaz D, Senbil N, Gurer Y (2011) Ocular findings in subacute sclerosing panencephalitis. Ocul Immunol Inflamm 19:135-138.